Increased Expression of the DNA-Binding Cytokine HMGB1 in Human Atherosclerotic Lesions
- 1 December 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 24 (12) , 2320-2325
- https://doi.org/10.1161/01.atv.0000145573.36113.8a
Abstract
Objective— Atherosclerosis is a chronic inflammatory response of the arterial wall to injury. High-mobility group box 1 (HMGB1) is a DNA-binding protein, which on release from cells exhibits potent inflammatory actions. We examined its expression in atherosclerotic lesions and regulation by cytokines. Methods and Results— In atherosclerotic lesions, HMGB1 protein is expressed by endothelial cells, some intimal smooth muscle cells, and macrophages. As atherosclerosis develops and progresses from fatty streaks to fibrofatty lesion, the number of HMGB1-producing macrophages increases markedly. Studies using the THP-1 cell line indicated that HMGB1 mRNA expression could be markedly upregulated by inflammatory cytokines, interferon (IFN)-γ, tumor necrosis factor (TNF)-α and also transforming growth factor (TGF)-β. IFN-γ, TNF-α, TWEAK, and TGF-β induced an intracellular redistribution of HMGB1 and stimulated secretion by THP-1 cells and human blood monocytes. Inhibitors of MEK1/MEK2, protein kinase C, and PI-3/Akt, which inhibit lysosomal degranulation and mRNA translation, attenuated cytokine-induced HMGB1 secretion. Conclusions— Macrophage is the major cell type responsible for HMGB1 production in human atherosclerotic lesions. Inflammatory cytokines and TGF-β increase HMGB1 expression and secretion by monocyte/macrophages. HMGB1 appears to be a common mediator of inflammation induced by inflammatory cytokines and is likely to contribute to lesion progression and chronic inflammation. The expression and regulation of high-mobility group box 1 (HMGB1) proinflammatory cytokine in human atherosclerosis were examined. HMGB1 is mostly expressed by macrophages and its expression increases during atherogenesis. Inflammatory cytokines upregulate HMGB1 expression and secretion. HMGB1 is a common mediator of inflammation and may contribute to atherosclerotic lesion progression.Keywords
This publication has 40 references indexed in Scilit:
- Transforming Growth Factor-α Attenuates N-Methyl-D-aspartic Acid Toxicity in Cortical Cultures by Preventing Protein Synthesis Inhibition through an Erk1/2-dependent MechanismPublished by Elsevier ,2003
- Tumor Necrosis Factor-α Induces Early-Onset Endothelial Adhesivity by Protein Kinase Cζ–Dependent Activation of Intercellular Adhesion Molecule-1Circulation Research, 2003
- High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokineArthritis & Rheumatism, 2003
- Activation of Endothelial Nitric-Oxide Synthase by Tumor Necrosis Factor-α: A Novel Pathway Involving Sequential Activation of Neutral Sphingomyelinase, Phosphatidylinositol-3′ kinase, and AktMolecular Pharmacology, 2003
- Transduction of Growth or Mitogenic Signals into Translational Activation of TOP mRNAs Is Fully Reliant on the Phosphatidylinositol 3-Kinase-Mediated Pathway but Requires neither S6K1 nor rpS6 PhosphorylationMolecular and Cellular Biology, 2002
- Cytochromeb558–Dependent NAD(P)H Oxidase–Phox Units in Smooth Muscle and Macrophages of Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Receptor for Advanced Glycation End Products (RAGE) Signaling Induces CREB-dependent Chromogranin Expression during Neuronal DifferentiationJournal of Biological Chemistry, 2002
- Activation of eNOS in rat portal hypertensive gastric mucosa is mediated by TNF-α via the PI 3-kinase-Akt signaling pathwayHepatology, 2002
- TNFα induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2Atherosclerosis, 2001
- Tissue specificity of nucleo‐cytoplasmic distribution of HMG1 and HMG2 proteins and their probable functionsEuropean Journal of Biochemistry, 1989